Literature DB >> 10877990

Mortality and morbidity associated with early-onset preeclampsia.

D J Murphy1, G M Stirrat.   

Abstract

OBJECTIVE: To examine the management of early-onset preeclampsia and its maternal and fetal morbidity and mortality.
DESIGN: Retrospective cohort study of 49,812 births at a university teaching hospital between June 1986 and March 1997. Seventy-one women were identified with a diagnosis of preeclampsia with an onset at less than 30 completed weeks of gestation.
RESULTS: The incidence of very preterm preeclampsia was 1 in 682 total births. The mean diagnosis to delivery interval (range) was 14 days (0-49 days). There were no maternal deaths. Fifteen women (21%) had developed HELLP/ELLP syndrome, 9 (13%) had renal failure, 1 (1.4%) had eclampsia, and 11 (15%) had an abruption. Five women (7%) had a termination of pregnancy, 57 (80%) were delivered by cesarean section, and 4 (5%) required a classical incision. There were 12 intrauterine deaths (16%), 9 neonatal deaths (12%), and 52 neonatal survivors (72%). Two of the survivors were known to have neurological impairment at the 2-year follow-up.
CONCLUSIONS: A conservative approach to the management of early-onset preeclampsia results in a good obstetric outcome for the majority of fetuses, but this must be balanced against the significant risk of morbidity to the mothers.

Entities:  

Mesh:

Year:  2000        PMID: 10877990     DOI: 10.1081/prg-100100138

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  21 in total

1.  Association between cytokine profile and transcription factors produced by T-cell subsets in early- and late-onset pre-eclampsia.

Authors:  Vanessa R Ribeiro; Mariana Romao-Veiga; Graziela G Romagnoli; Mariana L Matias; Priscila R Nunes; Vera Therezinha M Borges; Jose C Peracoli; Maria Terezinha S Peracoli
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

2.  Maternal and neonatal separation and mortality associated with concurrent admissions to intensive care units.

Authors:  Joel G Ray; Marcelo L Urquia; Howard Berger; Marian J Vermeulen
Journal:  CMAJ       Date:  2012-10-22       Impact factor: 8.262

3.  Population-based biomarker screening and the development of severe preeclampsia in California.

Authors:  Véronique Taché; Rebecca J Baer; Robert J Currier; Chin-Shang Li; Dena Towner; L Elaine Waetjen; Laura L Jelliffe-Pawlowski
Journal:  Am J Obstet Gynecol       Date:  2014-03-14       Impact factor: 8.661

4.  Why is there a modifying effect of gestational age on risk factors for cerebral palsy?

Authors:  C Greenwood; P Yudkin; S Sellers; L Impey; P Doyle
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

5.  Hepatic capsular rupture in pregnancy.

Authors:  Charlotte J Frise; Peyton Davis; Graham Barker; Douglas Wilkinson; Lucy Mackillop
Journal:  Obstet Med       Date:  2016-10-09

6.  Role of IL-6 -174(G/C) promoter polymorphism in the etiology of early-onset preeclampsia.

Authors:  Sabnavis Sowmya; Aruna Ramaiah; Pratibha Nallari; Akka Jyothy; Ananthapur Venkateshwari
Journal:  Inflamm Res       Date:  2015-04-28       Impact factor: 4.575

7.  Maternal complications associated with severe preeclampsia.

Authors:  A Nankali; Sh Malek-Khosravi; M Zangeneh; M Rezaei; Z Hemati; M Kohzadi
Journal:  J Obstet Gynaecol India       Date:  2012-09-27

8.  STAT3-mediated effects of methyltransferase inhibitor 5-aza-2'-deoxycytidine on preeclampsia.

Authors:  Xiaoli Zhang; Gang Wang; Hui Li; Xiangming Jiang; Xiaoyong Zhao
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 9.  Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines.

Authors:  Elizabeth Phipps; Devika Prasanna; Wunnie Brima; Belinda Jim
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 8.237

10.  Maternal history and uterine artery Doppler in the assessment of risk for development of early- and late-onset preeclampsia and intrauterine growth restriction.

Authors:  Elisa Llurba; Elena Carreras; Eduard Gratacós; Miquel Juan; Judith Astor; Angels Vives; Eduard Hermosilla; Ines Calero; Pilar Millán; Bárbara García-Valdecasas; Lluís Cabero
Journal:  Obstet Gynecol Int       Date:  2009-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.